Cleveland-Cliffs Inc. (NYSE: CLF): J.P. Morgan started coverage with a Neutral rating and an $18 price target. That compares with a $20.77 consensus target and Tuesday’s closing print of $14.77.
Five9 Inc. (NASDAQ: FIVN): Roth MKM resumed coverage with a Buy rating and an $80 target price. The consensus target is $83.75. The shares closed over 6% lower on Tuesday at $60.05.
Infosys Ltd. (NASDAQ: INFY): J.P. Morgan started coverage with a Neutral rating and a target price of $14. The consensus target is $18.34, and shares closed on Tuesday at $15.53.
Integra Lifesciences Holdings Corp. (NASDAQ: IART): Citigroup cut its Neutral rating to Sell and its $59 target price to $39. The consensus is $57.40 for now. Tuesday’s $40.48 close was down 20% on the day after the downgrade.
I3 Verticals Inc. (NASDAQ: IIIV): BTIG Research resumed coverage with a Buy rating and a $28 price target. The posted consensus target is $31.17. The shares closed on Tuesday at $23.75.
Knight-Swift Transportation Holdings Inc. (NYSE: KNX): Stifel resumed coverage with a Buy rating and a $63 target price. The consensus target is $65.11. The stock closed on Tuesday at $55.25.
Microsoft Corp. (NASDAQ: MSFT): Jefferies reiterated a Buy rating. Its $350 target price is higher than the $331.45 consensus target and Tuesday’s close at $315.26.
Myriad Genetics Inc. (NASDAQ: MYGN): When Goldman Sachs upgraded the stock Buy from Sell, it also raised its $18 target price to $25, above the $21.56 consensus figure. Tuesday’s close at $22.68 was up over 12% for the day on the upgrade.
Nucor Corp. (NYSE: NUE) J.P. Morgan started coverage with an Underweight rating and a $130 target price. The consensus target is $148.46. Shares were last seen on Tuesday trading at $136.92.
Quanterix Inc. (NASDAQ: QTRX): The Goldman Sachs upgrade to Buy from Neutral included a target price hike to $27 from $13. The consensus target is $19.25. The stock closed on Tuesday at $21.18, which was up 13% for the day on the upgrade.
ResMed Inc. (NYSE: RMD): UBS initiated coverage with a Buy rating and a $290 target price. The consensus target is $258. Tuesday’s final trade was for $222.55 a share.
Sponsored: Find a Qualified Financial Advisor
Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.
